Allyx Therapeutics, Inc.
PrivateLast Round
Series A
May 11, 2026
Total Funding Raised
$11.13M
Company Overview
Allyx Therapeutics, Inc. is a drug discovery company developing a first-in-class oral therapy to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allyx Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
Allyx Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 11, 2026 | ||||
| Seed Round | Mar 3, 2026 | ||||
| Grant | Oct 15, 2024 | ||||
| Series A | Jun 1, 2021 | ||||
| Pre Seed | Apr 3, 2019 |
Key People
Founding team and executive leadership
Allyx Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed |
| NIH RADx | Grant |
| Elm Street Ventures | Series A |
| Life Science Angels | Series A |
| Harrington Discovery Institute | Series A |
| Spring Mountain Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$26.4M raised in an early stage VC round.
Allyx Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allyx Therapeutics, Inc.'s valuation, stock price, and market status.
